Chemiluminescence and LC–MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers
- 16 April 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 35 (2) , 277-287
- https://doi.org/10.1016/s0731-7085(03)00531-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- NO-aspirin: mechanism of action and gastrointestinal safetyDigestive and Liver Disease, 2003
- Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic studyGastroenterology, 2003
- Characterization of the Magnitude and Kinetics of Xanthine Oxidase-Catalyzed Nitrate Reduction: Evaluation of Its Role in Nitrite and Nitric Oxide Generation in Anoxic TissuesBiochemistry, 2003
- Methodologies for the Sensitive and Specific Measurement of S -nitrosothiols, Iron-nitrosyls, and Nitrite in Biological SamplesFree Radical Research, 2003
- Concomitant presence of N-nitroso and S-nitroso proteins in human plasmaFree Radical Biology & Medicine, 2002
- Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosisProceedings of the National Academy of Sciences, 2002
- IL-1β Converting Enzyme Is a Target for Nitric Oxide-Releasing Aspirin: New Insights in the Antiinflammatory Mechanism of Nitric Oxide-Releasing Nonsteroidal Antiinflammatory DrugsThe Journal of Immunology, 2000
- A comparison of the anti‐inflammatory and anti‐nociceptive activity of nitroaspirin and aspirinBritish Journal of Pharmacology, 2000
- Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in ratsLife Sciences, 1996
- Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium(III) reduction with chemiluminescence detectionAnalytical Chemistry, 1989